Cargando…
Drug screening and development from the affinity of S protein of new coronavirus with ACE2
Recently, various studies have shown that angiotensin-converting enzyme 2 (ACE2) acts as the “doorknob” that can be bound by the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which conduces to its entrance to the host cells, and plays an important role in corona viru...
Autores principales: | Jiang, Yue-Peng, Zhao, Xiao-Xuan, Lv, Hui-Qing, Wen, Cheng-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545154/ https://www.ncbi.nlm.nih.gov/pubmed/33034780 http://dx.doi.org/10.1007/s10096-020-04048-7 |
Ejemplares similares
-
Affinity Capture Elution (ACE) ELISA Method Development and Validation for Novel RPH-104 Drug Immunogenicity Evaluation
por: Kolganova, Maria A., et al.
Publicado: (2022) -
Human coronaviruses and therapeutic drug discovery
por: Song, Lan-Gui, et al.
Publicado: (2021) -
Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
por: Lu, Jiayu, et al.
Publicado: (2021) -
Harnessing coronavirus spike proteins' binding affinity to ACE2 receptor through a novel baculovirus surface display system
por: Wang, Lin, et al.
Publicado: (2022) -
High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses
por: Sims, Joshua J., et al.
Publicado: (2022)